参考文献/References:
[1] Shanmugam VB, Harper R, Meredith I, et al. An overview of PCI in the very elderly[J]. J Geriatr Cardiol,2015,12(2):174-184.
[2] 杨跃进,杨进刚,袁晋青,等. 高龄老年（≥75岁）急性冠状动脉综合征患者规范化诊疗中国专家共识[J]. 中国循环杂志,2018,33(8):732-750.
[3] Zhang HP, Ai H, Zhao Y, et al. Effect of chronic total occlusion percutaneous coronary intervention on clinical outcomes in elderly patients[J]. Am J Med Sci,2018,355(2):174-182.
[4] Chang KW,Arbit B,Hsu JC. Antithrombotic regimens in patients with atrial fibrillation and coronary artery disease after percutaneous coronary intervention:a focused review[J]. Int J Cardiol,2017,243:263-269.
[5] Groves EM,Bhatt DL,Steg PG,et al. Incidence,predictors,and outcomes of acquired thrombocytopenia after percutaneous coronary intervention: a pooled, patient-level analysis of the CHAMPION trials (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition)[J]. Circ Cardiovasc Interv,2018,11(4):e5635.
[6] 唐熠达. 聚焦中国实践,遵循中国指南从2015中国STEMI指南更新谈抗栓治疗[J]. 浙江医学,2015,37(19):1563-1564.
[7] 李小鹰. 《高龄老年冠心病诊治中国专家共识》解读[J]. 健康管理,2017,(3):73-76.
[8] Faustino A,Mota P,Silva J. Non-ST-elevation acute coronary syndromes in octogenarians:applicability of the GRACE and CRUSADE scores[J]. Rev Port Cardiol,2014,33(10):617-627.
[9] Bueno H,Betriu A,Heras M,et al. Primary angioplasty vs. fibrinolysis in very old patients with acute myocardial infarction:TRIANA (TRatamiento del Infarto Agudo de miocardio eN Ancianos) randomized trial and pooled analysis with previous studies[J]. Eur Heart J,2011,32(1):51-60.
[10] Antonsen L,Jensen LO, Thayssen P.Outcome and safety of same-day-discharge percutaneous coronary interventions with femoral access:a single-center experience[J]. Am Heart J,2013,165(3): 393-399.
[11] Grinces C. SENIOR PAMI: a prospective randomized trial of primary angioplasty and thrombolytic therapy in elderly patients with acute myocardial infarction[M]. Presented at: Transcatheter cardiovascular therapeutics 2005: Oct 19, 2005:Washington, DC, USA.
[12] de Boer SP,Barnes EH,Westerhout CM,et al. High-risk patietns with ST-elevation myocardial infarction device greatest absolute benefit from primary percutaneous coronary intervention:results from the primary coronary angioplasty trialist versus thrombolysis (PCAT)-2 collaboration[J]. Am Heart J,2011,161:500-507.
[13] Peiyuan H,Jingang Y,Haiyan X,et al. The comparison of the outcomes between primary PCI, fibrinolysis, and no reperfusion in patients≥75 years old with ST-segment elevation myocardial infarction:results from the Chinese Acute Myocardial Infarction (CAMI) registry[J]. PLoS One,2016,11(11):e165672.
[14] Devlin G,Gore JM,Elliott J,et al. Management and 6-month outcomes in elderly and very elderly patients with high-risk non-ST-elevation acute coronary syndromes:The Global Registry of Acute Coronary Events[J]. Eur Heart J,2008,29(10):1275-1282.
[15] Bach RG,Cannon CP,Weintraub WS,et al. The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes[J]. Ann Intern Med,2004,141(3):186-195.
[16] Kolte D,Khera S,Palaniswamy C,et al. Early invasive versus initial conservative treatment strategies in octogenarians with UA/NSTEMI[J]. Am J Med,2013,126(12):1076-1083.
[17] Yoon YH,Lee PH,Ahn JM,et al. Long-term trends of treatment effect of stenting or bypass surgery in patients with ostial or shaft left main coronary artery disease[J]. Catheter Cardiovasc Interv,2019, Feb 5. DOI:10.1002/ccd.28119.
[18] Bertrand OF,de Larochelliere R,Rodes-Cabau J,et al. A randomized study comparing same-day home discharge and abciximab bolus only to overnight hospitalization and abciximab bolus and infusion after transradial coronary stent implantation[J]. Circulation,2006,114(24):2636-2643.
[19] Moalem K,Baber U,Chandrasekhar J,et al. Incidence,predictors,and outcomes of DAPT disruption due to non-compliance vs. bleeding after PCI:insights from the PARIS Registry[J]. Clin Res Cardiol,2019,108(6):643-650.
[20] Murphy NF,Simpson CR,Jhund PS,et al. A national survey of the prevalence,incidence,primary care burden and treatment of atrial fibrillation in Scotland[J]. Heart,2007,93(5):606-612.
[21] Sun B,Liu Z,Yin H,et al. Intralesional versus intracoronary administration of glycoprotein Ⅱb/Ⅲa inhibitors during percutaneous coronary intervention in patients with acute coronary syndromes:a meta-analysis of randomized controlled trials[J]. Medicine(Baltimore),2017,96(40):e8223.
[22] Aghajani H,Nezami P,Shafiee A,et al. Predictors of long-term major adverse cardiac events following percutaneous coronary intervention in the elderly[J]. Arch Iran Med,2018,21(8):344-348.
[23] Jaber WA,Lennon RJ,Mathew V,et al. Application of evidence-based medical therapy is associated with improved outcomes after percutaneous coronary intervention and is a valid quality indicator[J]. J Am Coll Cardiol,2005,46(8):1473-1478.
[24] Gao L,Hu X,Liu YQ,et al. Comparison of coronary DES and BMS in octogenarians:a systematic review and meta-analysis[J]. J Geriatr Cardiol,2013,10(4):336-343.
[25] Merinopoulos I,Gunawardena T,Wickramarachchi U,et al.Percutaneous coronary intervention in the elderly: are drug-coated balloons the future?[J]. Curr Cardiol Rev,2018,14(1):45-52.
[26] Shreenivas S,Kaneko T,Tang G. Predicting the future of TAVR:an obituary to open aortic valve replacement?[J]. Curr Opin Cardiol,2019,34(2):112-123.
[27] Baek MS,Park S,Choi JH,et al. Mortality and prognostic prediction in very elderly patients with severe pneumonia[J]. J Intensive Care Med,2019,1(14):1-6.
[28]Rasania SP,Chamaria S,Vengrenyuk Y,et al. Percutaneous coronary intervention outcomes in very elderly patients from a single large-volume tertiary care center, specifically focusing on nonagenarians[J]. JACC Cardiovasc Interv,2017,10(12):1273-1274.
[29] Psaltis PJ,Nicholls SJ. Management of acute coronary syndrome in the very elderly[J]. Lancet,2016,387(10023):1029-1030.
相似文献/References:
[1]林远龙,刘现亮.无复流现象:从基础到临床[J].心血管病学进展,2016,(1):53.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.014]
LIN Yuanlong,LIU Xianliang.From Bench to Bed:No-reflow Phenomenon[J].Advances in Cardiovascular Diseases,2016,(6):53.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.014]
[2]赵劲东,综述,董平栓,等.合并多支血管病变的急性ST段抬高型心肌梗死介入术治疗策略的研究进展[J].心血管病学进展,2016,(3):295.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.021]
ZHAO Jindong,DONG Pingshuan.Research Progress of Interventional Therapy in Patients with ST-elevation
Myocardial Infarction and Multivessel Disease[J].Advances in Cardiovascular Diseases,2016,(6):295.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.021]
[3]余正春,综述,马小静,等.急性心肌梗死并发心源性休克的治疗进展[J].心血管病学进展,2016,(4):441.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.029]
YU Zhengchun,MA Xiaojing.Treatment of Cardiogenic Shock Complicating Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2016,(6):441.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.029]
[4]元洋洋 李波.Selvester QRS评分系统研究进展[J].心血管病学进展,2019,(7):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
YUAN YangyangLI Bo.Research Progress of Selvester QRS Scoring System[J].Advances in Cardiovascular Diseases,2019,(6):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
[5]翁子骞 于波.血栓抽吸在急性ST段抬高型心肌梗死中的研究进展[J].心血管病学进展,2019,(7):1035.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.018]
WENG ZiqianYU Bo.Thrombus aspiration in acute ST-segment elevation myocardial infarction[J].Advances in Cardiovascular Diseases,2019,(6):1035.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.018]
[6]林莉 韦铁民.急性心肌梗死后心脏破裂[J].心血管病学进展,2019,(7):1039.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]
LIN LiWEI Tiemin.Post-infarction Cardiac Rupture[J].Advances in Cardiovascular Diseases,2019,(6):1039.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]
[7]杨颜瑜,苏星,谭敏,等.炎症指标与急性心肌梗死研究进展[J].心血管病学进展,2019,(6):947.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.027]
YANG Yanyu,SU Xing,TAN Min,et al.Relationship Between Inflammation Index and Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(6):947.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.027]
[8]崔小豪 杨志明.和肽素在急性心肌梗死中的研究进展[J].心血管病学进展,2019,(5):726.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]
CUI Xiaohao,YANG Zhiming.Copeptin in Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(6):726.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]
[9]潘甜 马康华.急性心肌梗死经皮冠脉介入术后冠状动脉无复流的预防和治疗进展[J].心血管病学进展,2019,(5):730.[doi:10.16806/j.cnki.issn.1004-3932019.05.017]
PAN Tian,MA Kanghua.Prevention and Treatment of Coronary Artery No-Reflow after Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(6):730.[doi:10.16806/j.cnki.issn.1004-3932019.05.017]
[10]朱建中 吴倩芸 刘峰.急性ST段抬高型心肌梗死“导管室误激活”的临床进展[J].心血管病学进展,2019,(5):739.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.019]
ZHU JianzhongWU QianyunLIU Feng.The Development of False-positive Activation of Cardiac Catheterization Laboratory with Acute ST Segment Elevation Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(6):739.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.019]